MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clcc.2018.08.002

Медицинская библиотека · Clinical colorectal cancer · 2018

Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.

Sunakawa Yu, Yang Dongyun, Cao Shu, Zhang Wu, Moran Miriana, Astrow Stephanie H, Hsiang Jack, Stephens Craig, Tsuji Akihito, Takahashi Takehiro, Tanioka Hiroaki, Negoro Yuji, Takagane Akinori, Tani Satoshi, Yamaguchi Tatsuro, Eto Tetsuya, Fujii Masashi, Ichikawa Wataru, Lenz Heinz-Josef

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Few clinical studies have investigated the association between neutrophil-lymphocyte ratio (NLR) and treatment with cetuximab-based chemotherapy in metastatic colorectal cancer (mCRC). The NLR may reflect immune cells modulating specific cytokine signals in the tumor microenvironment; however, which immune-related genes affect the NLR remain unclear.

PATIENTS AND

METHODS

In 77 patients with KRAS exon2 wild-type mCRC from prospective trials of first-line chemotherapy with cetuximab, expression levels of 354 immune-related genes were measured in tissue samples obtained from all patients by the HTG EdgeSeq Oncology Biomarker Panel. The association between the NLR and clinical outcomes was evaluated using the Spearman rank correlation coefficient. In addition, 2-sample t tests were performed to investigate which genes among the top 100 genes associated with survival had significantly different expression levels between the NLR-low and NLR-high groups among all measured genes.

RESULTS

NLR data were available for 71 patients. The NLR was associated with progression-free survival and overall survival (r = -0.24; P = .040 and r = -0.29; P = .010, respectively). When stratified by the median value of the NLR, the Kaplan-Meier curve of NLR-low versus NLR-high differed significantly for both progression-free survival (median, 11.8 vs. 9.1 months; P = .036) and overall survival (median, 42.8 vs. 26.7 months; P = .029). The 2-sample t test revealed that the expression levels of the LYZ, TYMP, and CD68 genes differed significantly between the NLR-low and NLR-high groups (t test P-value < .005; false discovery rate P-value < .15).

CONCLUSION

NLR is significantly associated with survival in patients with mCRC treated with first-line chemotherapy with cetuximab. Genes encoding for activities on macrophages may affect the NLR.

Для цитирования: Sunakawa Yu, Yang Dongyun, Cao Shu, Zhang Wu, Moran Miriana, Astrow Stephanie H, Hsiang Jack, Stephens Craig, Tsuji Akihito, Takahashi Takehiro, Tanioka Hiroaki, Negoro Yuji, Takagane Akinori, Tani Satoshi, Yamaguchi Tatsuro, Eto Tetsuya, Fujii Masashi, Ichikawa Wataru, Lenz Heinz-Josef. Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer.. Clinical colorectal cancer. 2018. DOI: 10.1016/j.clcc.2018.08.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.